Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis

Non‐alcoholic fatty liver disease is a public health problem worldwide associated with high morbidity and hepatic steatosis, but no effective therapeutic interventions. Magnesium isoglycyrrhizinate (MGIG), a derivative of an active component of Glycyrrhiza glabra, is widely used for the treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wenjiao, Xu, Shiyu, Guo, Huijie, Lu, Li, Liu, Jie, Wang, Guangji, Hao, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339216/
https://www.ncbi.nlm.nih.gov/pubmed/32410294
http://dx.doi.org/10.1111/jcmm.15230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339216/
https://www.ncbi.nlm.nih.gov/pubmed/32410294
http://dx.doi.org/10.1111/jcmm.15230

Ejemplares similares